[Mental disease, existence of diagnostic, use of psychotropic medication: differences by autonomous communities under the national health survey 2006].
BACKGROUND
Most of the studies on psychological distress in Spain have been conducted in small geographical areas or specific population groups. However, there are no studies that provide representative data for each Autonomous Community (AC). The objectives of this paper are to determine, both in Spain and in the AC, the prevalence of psychological distress, diagnosis, use of psychoactive medication, social support and self-perceived health, as well as to study the association between psychological distress and the rest of the variables.


METHODS
Cross-sectional study, using data from the 2006 National Health Survey, that was completed by 29,478 persons.


METHODS
sociodemographics, psychological distress (GHQ-12), self-perceived health, mental disorder diagnosis, functional social support (Duke) and use and prescription of psychoactive medication.


RESULTS
The prevalence of psychological distress in Spain was 20,1%; the highest prevalence was found in Canary Islands (28,2%) and the lowest in La Rioja (12,2%). Among those who presented psychological distress, 62,4% had never received a mental disorder diagnosis, and 71,6% had not used psychoactive medication in the last year. The highest prevalences of non-diagnosed cases (81,8%) and cases non-treated with psychoactive medication (83,1%) were found in La Rioja, whereas the lowest prevalences were found in Asturias. Eight percent of the persons who presented psychological distress had low social support and 63,8% reported bad self-perceived health.


CONCLUSIONS
Psychological distress is a prevalent phenomenon, and more than half of the persons who suffer it receive neither a diagnosis nor psychoactive medication. Moreover, there are considerable differences between the AC.
Ricci-Cabello
Ignacio
I
Escuela Andaluza de Salud Pública, Granada, España. ignacio.ricci.easp@juntadeandalucia.es
Ruiz-Pérez
Isabel
I
Plazaola-Castaño
Juncal
J
Montero-Piñar
Isabel
I
D000293:Adolescent; D000328:Adult; D016001:Confidence Intervals; D003430:Cross-Sectional Studies; D003627:Data Interpretation, Statistical; D005260:Female; D019538:Health Care Surveys; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D008875:Middle Aged; D015995:Prevalence; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012944:Social Support; D012959:Socioeconomic Factors; D013030:Spain / Q000453:epidemiology; D013315:Stress, Psychological / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D011795:Surveys and Questionnaires
D011619:Psychotropic Drugs